Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer
about
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancyPharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapyPersonalized treatment of severe pneumonia in cancer patients.Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial.Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.[Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].Individualized dosing with axitinib: rationale and practical guidance.UPLC-MS/MS method for therapeutic drug monitoring of 10 antibiotics used in intensive care units.
P2860
Q28080607-CDC9CE5F-DB97-45E9-A2FA-49F833B4F8EEQ33797868-7F9CEF15-0A0F-4808-9B37-AC9E08D0F634Q34462071-790DEE0D-33DE-41B9-808F-BCD2185CA4BEQ38613281-540F832D-57FF-4C15-9012-38B766AE7AC8Q38625059-0357B42F-0889-4422-8FF5-9CE7E4599A22Q40156961-06ADF49F-3D21-490A-9BC2-FB323B53D102Q40186288-EA9C5CFF-6F80-49B7-939F-171AC5E86CE8Q40586250-C5DCB65D-C5A4-4E49-88B1-D2E792B9897CQ40962124-40D0CABE-9206-4B3A-B110-D0CBF6B63FE2Q47271327-C1449818-D884-49D2-AD29-89174692C2A1Q48016535-11915CF1-BD0B-4DA3-8B70-517FCBFC1BD8
P2860
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@ast
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@en
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@nl
type
label
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@ast
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@en
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@nl
prefLabel
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@ast
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@en
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@nl
P2860
P356
P1476
Pharmacokinetic and pharmacody ...... herapy in patients with cancer
@en
P2093
U. Theuretzbacher
P2860
P304
P356
10.1093/CID/CIS210
P407
P577
2012-06-01T00:00:00Z